Cargando…
Oncological outcome, complications, lower urinary tract symptoms, and health-related quality of life after low-dose-rate salvage brachytherapy for recurrent prostate cancer following primary radiotherapy: a report of 8 cases
PURPOSE: We evaluated our experience with low-dose-rate salvage brachytherapy for local recurrence after primary prostate radiotherapy, and described the changes in lower urinary tract symptoms and health-related quality of life. MATERIAL AND METHODS: Between 2011 and 2016, eight men with local recu...
Autores principales: | Miyake, Makito, Tanaka, Nobumichi, Asakawa, Isao, Hori, Shunta, Morizawa, Yosuke, Nakai, Yasushi, Anai, Satoshi, Torimoto, Kazumasa, Aoki, Katsuya, Marugami, Nagaaki, Hasegawa, Masatoshi, Fujii, Tomomi, Konishi, Noboru, Fujimoto, Kiyohide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611453/ https://www.ncbi.nlm.nih.gov/pubmed/28951757 http://dx.doi.org/10.5114/jcb.2017.69235 |
Ejemplares similares
-
The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions
por: Miyake, Makito, et al.
Publicado: (2019) -
Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute
por: Miyake, Makito, et al.
Publicado: (2017) -
Salvage brachytherapy for seminal vesicle recurrence after initial brachytherapy for prostate cancer: a case report
por: Hori, Shunta, et al.
Publicado: (2014) -
Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study
por: Miyake, Makito, et al.
Publicado: (2014) -
Quality of life worsened the most severely in patients immediately after intensity-modulated radiotherapy for prostate cancer
por: Nakai, Yasushi, et al.
Publicado: (2018)